The Simcyp ® Population-based ADME Simulator
The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Abstract
The Simcyp population-based absorption, distribution, metabolism and excretion simulator is a platform and database for 'bottom-up' mechanistic modelling and simulation of the processes of oral absorption, tissue distribution, metabolism and excretion of drugs and drug candidates in healthy and disease populations. It combines experimental data generated routinely during preclinical drug discovery and development from in vitro enzyme and cellular systems and relevant physicochemical attributes of compound and dosage form with demographic, physiological and genetic information on different patient populations. The mechanistic approach implemented in the Simcyp Simulator allows simulation of complex absorption, distribution, metabolism and excretion outcomes, particularly those involving multiple drug interactions, parent drug and metabolite profiles and time- and dose-dependent phenomena such as auto-induction and auto-inhibition.This review describes the framework and organisation of the simulator and how it combines the different categories of information.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Simcyp® Simulator Version 24 (Certara) provides curated virtual populations spanning diverse demographics and disease states, with detailed CYP and transporter ontogeny modules.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [92]
In the citing paper
“The platform incorporates the Advanced Dissolution, Absorption and Metabolism (ADAM) model for mechanistic oral absorption simulation alongside its long-established disposition framework, complementing its strengths in CYP- and transporter-mediated DDI prediction and pediatric extrapolation [22,92].”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [92]
In the citing paper
“Simcyp® has become the most widely used platform for regulatory PBPK submissions, and its population-based approach generates predicted exposure distributions rather than single-point estimates, enabling risk-based decision-making.”
From Beyond Body Weight: A Comprehensive Review of Allometric Scaling in Drug Development for Human Dose Predictions (2026) · cites this paper as [92]
In the citing paper
“In Simcyp, applying the full PBPK option, the distribution to tissues is described as perfusion limited distribution, implemented by K p values. 13”
From Does the choice of applied physiologically‐based pharmacokinetics platform matter? A case study on simvastatin disposition and drug–drug interaction (2022) · cites this paper as [13]
Citations
Cites
Numerical solution of stochastic differential equations
(2016) · doi:10.5194/gmd-2016-45-rc1 · Cited by 5,002
Numerical recipes: the art of scientific computing
Press, W. H., Flannery, B. P., Teukolsky, S. A., Vetterling, W. T., & Chipperfield, J. R. (1987) · Analytica Chimica Acta · doi:10.1016/s0003-2670(00)82860-3 · Cited by 3,304
ADMET in silico modelling: towards prediction paradise?
van de Waterbeemd, H., & Gifford, E. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1032 · Cited by 1,863 · cited 1×
“It is estimated that by 2016 about 20% of pharmaceutical R&D expenditure will be invested in this approach [4] and that by 2020 new computer-based technologies will create a greater understanding of the biology of disease, enabling the evolution of a ‘Virtual Man’ to enhance prediction of the effects of new drug candi…”
BackgroundRodgers, T., & Rowland, M. (2006) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20502 · Cited by 946 · cited 1×
“For volume of distribution, an in vivo value can be entered directly or a value can be predicted using the Rodgers and Rowland [48,49] method or the Poulin and Theil [50,51] method as corrected by Berezhkovskiy [52] .”
MethodRodgers, T., Leahy, D., & Rowland, M. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20322 · Cited by 776 · cited 1×
“For volume of distribution, an in vivo value can be entered directly or a value can be predicted using the Rodgers and Rowland [48,49] method or the Poulin and Theil [50,51] method as corrected by Berezhkovskiy [52] .”
MethodDifferential-Algebraic Equations: Analysis and Numerical Solution
Kunkel, P., & Mehrmann, V. (2006) · Cited by 733
Differential-Algebraic Equations: Analysis and Numerical Solution
Kunkel, P., & Mehrmann, V. (2006) · EMS Textbooks in Mathematics · doi:10.4171/017 · Cited by 615 · cited 1×
“In many cases, the differential equations do not have closed form solutions, and numerical integration is required [55-57] .”
BackgroundPoulin, P., & Theil, F. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10005 · Cited by 568 · cited 1×
“For volume of distribution, an in vivo value can be entered directly or a value can be predicted using the Rodgers and Rowland [48,49] method or the Poulin and Theil [50,51] method as corrected by Berezhkovskiy [52] .”
MethodJohnson, T. N., Rostami-Hodjegan, A., & Tucker, G. T. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645090-00005 · Cited by 530 · cited 3×
“The purpose of this article is to outline the framework and organisation of the Simulator for the first time; details of the algorithms and functions can be found elsewhere [14-16,22,23,31-35] .”
BackgroundSelf-citationSimulation and prediction of in vivo drug metabolism in human populations from in vitro data
Rostami-Hodjegan, A., & Tucker, G. T. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2173 · Cited by 530 · cited 3×
“The purpose of this article is to outline the framework and organisation of the Simulator for the first time; details of the algorithms and functions can be found elsewhere [14-16,22,23,31-35] .”
BackgroundMethodSelf-citation
Research works printed but not linked: 8
- Dong JQ, Gibbs BC, Emery M, et al. Applications of computer-aided pharmacokinetic and pharmacodynamic methods from drug discovery through registration. Curr Comput Aided Drug Des 2008;(4):54-66
- Jamei M Yang J Turner D et al. A novel physiologically-based mechanistic model for predicting oral drug absorption: the advanced dissolution absorption and metabolism (ADAM) model. The 4th World Conference on Drug Absorption Transport and Delivery; June 20th – 22nd 2007; Kanazawa Japan; 2007
- 10.3109/00498250701620700 · doi:10.3109/00498250701620700 · Paper page
- Yang JS, Jamei M, Heydari A, et al. Mechanism-based inhibition of CYP2D6 by MDMA and its implications for pharmacokinetics and toxicity; presented at: Thirty-Fourth Annual Meeting American College of Clinical Pharmacology. J Clin Pharmacol 2005;45(9):1094
- Schildt H. C++: the complete reference. Fourth editon Berkeley; London: Osborne/McGraw-Hill; 2000
- Blaszczak M Blaszczak M. Professional MFC with visual C++ 6. Fourth editon Birmingham UK: Wrox Press; 1999
- Liberty J Hurwitz D. Programming ASP.NET. Third editon Sebastopol Calif.: O'Reilly; 2005;704
- MacDonald M. SpringerLink (Online service). Beginning ASP.NET 3.5 in C# 2008. From novice to professional. Second Edition. Berkeley CA: Matthew MacDonald; 2008
Cited by
Computational Methods in Drug Discovery
Sliwoski, G., Kothiwale, S., Meiler, J., & Lowe, E. W. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007336 · Cited by 2,160
“In vitro metabolism data can be applied to the in vitro-in vivo extrapolation process to simulate whole-live and hepatic clearances for these virtual populations (Jamei et al., 2009).”
MethodPhysiologically-Based Pharmacokinetics in Drug Development and Regulatory Science
Rowland, M., Peck, C., & Tucker, G. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100540 · Cited by 662
Self-citationBasic Concepts in Physiologically Based Pharmacokinetic Modeling in Drug Discovery and Development
Jones, H., & Rowland‐Yeo, K. (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.41 · Cited by 626
New developments in anti-malarial target candidate and product profiles
Burrows, J. N., Duparc, S., Gutteridge, W. E., Hooft van Huijsduijnen, R., Kaszubska, W., Macintyre, F., Mazzuri, S., Möhrle, J. J., & Wells, T. N. C. (2017) · Malaria Journal · doi:10.1186/s12936-016-1675-x · Cited by 520
Zhao, P., Zhang, L., Grillo, J. A., Liu, Q., Bullock, J. M., Moon, Y. J., Song, P., Brar, S. S., Madabushi, R., Wu, T. C., et al. (2011) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2010.298 · Cited by 522
Metadata
- Authors
- Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A.
- Affiliations
- Simcyp (United Kingdom) (GB)
- Modelling & Simulation Group, Simcyp Limited, Blades Enterprise Centre, John Street, Sheffield, S2 4SU, UK ; ;
- Venue
- Expert Opinion on Drug Metabolism & Toxicology
- Publisher
- Informa UK Limited
- Published
- 2009-02
- Volume
- 5
- Issue
- 2
- Pages
- 211-223
- ISSN
- 1742-5255 (ISSN-L)
- 1744-7607
- OpenAlex
- W2009316291
- Cited by
- 533
- References
- 51
- Citations by year
- 2026: 24 · 2025: 32 · 2024: 21 · 2023: 29 · 2022: 32 · 2021: 39 · 2020: 20 · 2019: 26 · 2018: 33 · 2017: 39 · 2016: 28 · 2015: 30 · 2014: 31 · 2013: 36 · 2012: 40
- FWCI
- 32.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Expert Opinion on Drug Metabolism & Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Funders
- U.S. Food and Drug Administration
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- population pharmacokinetics, pharmacokinetic-pharmacodynamic modeling, oral drug absorption, tissue distribution, drug metabolism, drug excretion, mechanistic modeling, drug-drug interactions, autoinduction, autoinhibition, drug candidates, in vitro-in vivo extrapolation, physicochemical properties
- MeSH terms
- Administration, Oral, Animals, Computer Simulation, Dose-Response Relationship, Drug, Drug Evaluation, Preclinical, Pharmaceutical Preparations, Humans, Models, Biological, Pharmacokinetics, Time Factors, Tissue Distribution, Drug Design, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Simcyp ® Population-based ADME Simulator. https://app.cochat.ai/papers/10.1517/17425250802691074
- The paper
- Jamei, M., Marciniak, S., Feng, K., Barnett, A., Tucker, G., & Rostami-Hodjegan, A. (2009). The Simcyp ® Population-based ADME Simulator. Expert Opinion on Drug Metabolism & Toxicology. https://doi.org/10.1517/17425250802691074
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.